Brokerages Set Vitalhub Corp. (TSE:VHI) Price Target at C$10.05

Vitalhub Corp. (TSE:VHI) has earned an average rating of “Buy” from the five ratings firms that are covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is C$11.60.

VHI has been the subject of a number of research reports. TD Securities raised Vitalhub to a “strong-buy” rating in a research note on Monday, November 25th. Scotiabank set a C$14.00 price target on Vitalhub and gave the company an “outperform” rating in a research note on Thursday, January 30th. Finally, Canaccord Genuity Group increased their price target on Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research note on Thursday, January 16th.

Vitalhub Stock Performance

Shares of TSE VHI opened at C$11.75 on Thursday. The stock has a fifty day moving average price of C$11.34 and a two-hundred day moving average price of C$9.79. The firm has a market cap of C$597.49 million, a P/E ratio of 106.82, a PEG ratio of 1.18 and a beta of 1.26. Vitalhub has a 1 year low of C$4.95 and a 1 year high of C$12.09.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.